Feed AVEFF
AV

Avecho Biotechnology Limited AVEFF · OTC

$0.00 +0.00% (+$0.00)

Summary

31 / 100 · Bulios Score

What speaks for it

  • It holds more cash than debt: $6.60M against $227.2K.
  • The share price is below the Bulios Fair Price.
  • Out of every 100 AUD of revenue, 89 AUD is left as free cash.

What to watch

  • The company made a loss over the last 12 months.
  • Revenue growth is slowing: 0.9% a year over the last 3 years against 26% over 5 years.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap

Price against the Bulios Fair Price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

The company made a loss over the last 12 months, so there is no profit to set the price against.

Valuation in detail

Is it growing?

It is shrinking

Revenue (AUD)

Diluted EPS (AUD)

  • Analyst estimate

Revenue grew by 26% a year over 5 years. Over the last 3 years it grew by 0.9% a year.

Growth in detail

Does it make money?

Income figures for the last 12 months are not available.

Profitability in detail

Is it financially healthy?

Yes

It holds more cash than debt.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

No coverage

No analyst covers this stock.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.